Saladax Biomedical, Inc. (Saladax) is a healthcare diagnostics company, based in the US. The company develops immunoassays for the dose management of chemotherapy agents that helps to measure chemotherapy levels in the blood. Its products include 5-Fluorouacil, dotacexel, paclitaxel, cyclophosphamide, irinotecan, busulfan, lenalidomide, doxorubicin, thalidomide, imatinib myselate, tyrosine kinase inhib, gemicitabine, risperidone, vincristine and clozapine. Saladax focuses on oncology drug dose optimization, with a portfolio of thirteen proprietary cancer drug assays and two in anti-psychotics in various stages of development. The company is ISO 13485:2003 certified. It is partnered with AB Analitica, FALCO Biosystems, Genoxa, Kaan Med, Myriad and others. Saladax is headquartered in Bethlehem, Pennsylvania, the US.